Startup Intros
FeaturesPricingNewsletterEventsPartners
FeaturesPricingNewsletterEventsPartners
  1. Home
  2. /Organizations
  3. /Baird Capital
Baird Capital logo

Baird Capital

ActiveVenture Capital
Website LinkedIn
Updated: Jan 22, 2026 ·
AboutNewsFinancialsTeamDeep DiveFAQs

Quick Facts

Type
Investment Firm
Status
Active
Founded
1919
HQ
Illinois
IPO Status
Private

Subscribe, Save or Share

Get email updates

Financial History

Total Raised
N/A
Valuation
N/A

Leadership Team

Key people at Baird Capital.

JL
James Lowe
Associate
NN
Naofumi Nishi
Managing Director
KS
Katie Schoen
Vice President
DA
Daniel Almon
Principal
AE
Aidan Elliott
Investor
JA
Joanna Arras
Partner
JP
James Pavlik
Partner
JN
John Neis
Principal
NW
Nicole Walker
Partner, Venture Capital - Healthcare
FR
Frederick Robertson
Venture Partner
MH
Michael Holgate
Partner
GP
Gordon Pan
President
BS
Becca Schlagenhauf
Vice President
RO
Rob Ospalik
Partner
TS
Thomas Smith
Partner
DG
David Gregorka
Venture Partner
AK
Amy Kobe
Principal
AF
Andrew Ferguson
Partner
ML
Michael Liang
Venture Partner
JA
Jubril Ayanbunmi
Associate
TM
Timothy Marx
Venture Partner
BR
Benedict Rocchio
Partner
BK
Ben Kubik
Vice President
JB
James Benfield
Partner
MG
Matthew Gura
Associate
RW
Ross Wright
Venture Capital Associate
DH
Dennis Hall
Partner
Startup Intros

Making merit matter more than network. The intelligence layer for Venture fundraising.

Platform

FeaturesPricingBlogNewsletterEvents

Company

PartnersAboutPrivacyTerms

Connect

© 2026 Startup Intros. All rights reserved.

Leadership Team

Key people at Baird Capital.

James Lowe
James Lowe
Associate
Naofumi Nishi
Naofumi Nishi
Managing Director
Katie Schoen
Katie Schoen
Vice President
Daniel Almon
Daniel Almon
Principal
Aidan Elliott
Aidan Elliott
Investor
Joanna Arras
Joanna Arras
Partner
James Pavlik
James Pavlik
Partner
John Neis
John Neis
Principal
Nicole Walker
Nicole Walker
Partner, Venture Capital - Healthcare
Frederick Robertson
Frederick Robertson
Venture Partner
Michael Holgate
Michael Holgate
Partner
Gordon Pan
Gordon Pan
President
Becca Schlagenhauf
Becca Schlagenhauf
Vice President
Rob Ospalik
Rob Ospalik
Partner
Thomas Smith
Thomas Smith
Partner
David Gregorka
David Gregorka
Venture Partner
Amy Kobe
Amy Kobe
Principal
Andrew Ferguson
Andrew Ferguson
Partner
Michael Liang
Michael Liang
Venture Partner
Jubril Ayanbunmi
Jubril Ayanbunmi
Associate
Timothy Marx
Timothy Marx
Venture Partner
Benedict Rocchio
Benedict Rocchio
Partner
Ben Kubik
Ben Kubik
Vice President
James Benfield
James Benfield
Partner
Matthew Gura
Matthew Gura
Associate
Ross Wright
Ross Wright
Venture Capital Associate
Dennis Hall
Dennis Hall
Partner

Deep Dive

High-Level Overview

Baird Capital is a global investment firm specializing in venture capital, growth equity, and private equity investments primarily in B2B technology and services sectors. Their mission centers on partnering with founder- and entrepreneur-led companies to provide not only capital but also operational support and strategic guidance to accelerate growth. They focus on sectors where they have deep institutional knowledge, including pharma services, healthcare, software, and business services. Baird Capital plays a significant role in the startup ecosystem by leveraging its global resources, executive networks, and flexible capital solutions to help companies scale internationally and optimize operations[1][2][3][4].

Origin Story

Baird Capital is part of Baird, a financial services firm founded in 1919 in Milwaukee, Wisconsin. Over time, Baird Capital evolved into a distinct investment arm managing two complementary strategies: Global Private Equity and Venture Capital. The firm’s leadership includes experienced partners such as Jim Pavlik, Benedict Rocchio, and Mike Liang, who guide investments in early to late-stage companies. The firm has a long history of investing in over 300 companies, emphasizing founder collaboration and leveraging Baird’s global brand and relationships to support growth ambitions[2][4][5].

Core Differentiators

  • Unique Investment Model: Baird Capital offers flexible capital solutions ranging from $15M to $80M, investing across the full capital spectrum from venture to buyouts, with a focus exclusively on B2B technology and services.
  • Network Strength: The firm leverages a global platform and extensive executive networks to provide operational and strategic support beyond capital.
  • Track Record: With investments in over 300 companies, Baird Capital has a proven history of partnering with founders to build successful businesses.
  • Operating Support: They provide hands-on guidance in operational discipline, growth strategy, and international expansion, maintaining a founder-focused and collaborative culture[1][2][3][4].

Role in the Broader Tech Landscape

Baird Capital rides the trend of increasing demand for technology-enabled B2B services and outsourced pharma services, sectors underpinned by long-term macro drivers such as globalization and digital transformation. Their timing aligns with growing market needs for specialized capital and operational expertise to scale companies internationally. By focusing on founder-led businesses and leveraging global resources, Baird Capital influences the broader ecosystem by enabling innovation and growth in critical technology and healthcare verticals, helping startups transition into mature, global enterprises[1][3][4].

Quick Take & Future Outlook

Looking ahead, Baird Capital is poised to continue expanding its influence by deepening investments in high-growth B2B tech and healthcare sectors, particularly those benefiting from digital transformation and globalization. Trends such as AI integration, healthcare outsourcing, and SaaS adoption will likely shape their portfolio strategy. Their founder-centric approach and global platform position them well to support companies through scaling challenges and international expansion, reinforcing their role as a key partner in the evolving tech and services landscape[1][3][4]. This ongoing commitment ties back to their mission of being a trusted, growth-oriented partner for entrepreneurial companies worldwide.

Sources

  1. bairdcapital.com
  2. michiganvca.org
  3. bairdcapital.com
  4. bairdcapital.com
  5. rwbaird.com
  6. rwbaird.com

Financial History

Total Raised
N/A
Valuation
N/A

Investments Made

DateCompanyRoundLead Investor(s)Co-Investor(s)
Sep 1, 2025Pimly$2.0M Venture Round—Bessemer Venture Partners, High Alpha, MassMutual Ventures, Menlo Ventures, Jeff Richards
Jul 1, 2025Backstroke$3.0M Seed—Bessemer Venture Partners, High Alpha, MassMutual Ventures, Menlo Ventures, Jeff Richards
Mar 1, 2025Greenlight Biosciences$25.0M Series C——
Jan 1, 2025Alleviant Medical$90.0M Venture Round—RiverVest, S3 Ventures
Nov 1, 2024Roon$15.0M Series A—BoxGroup, Contrary Capital, FirstMark Capital, Forerunner Ventures, La Famiglia, Blake Wu, Portal Ventures, Sequoia Capital, Stash Ventures, Susa Ventures, Target Global, TMV, WGI Group, Aaron Skonnard, Kim Perell, Noah Goodhart, Thomas Plantenga
Aug 1, 2024ModelOp$10.0M Series B—The Valley Fund, Jim McLean
Jun 1, 2024Eko Health$41.0M Series D—Vasudev Bailey, Artis Ventures (AV), Echo Health Ventures, Endeavor Venture Funds, Highland Capital Partners, Hoxton Ventures, Oak HC/FT, Optum Ventures, Pieter Kemps, Presight Capital, Questa Capital, Radical Ventures, The House Fund, Tiger Global Management, What If Ventures, Zetta Venture Partners, Michael Baum, Tim Kendall
May 1, 2024Backstroke$5.0M Seed—Bessemer Venture Partners, High Alpha, MassMutual Ventures, Menlo Ventures, Jeff Richards
Apr 1, 2024Vidyard$15.0M Venture Round—Bain Capital Ventures, Battery Ventures, Bessemer Venture Partners, Bread and Butter Ventures, High Alpha, IrishAngels, MassMutual Ventures, Matchstick Ventures, Menlo Ventures, Motivate Ventures, Jeff Richards, Schematic Ventures, Social Starts, Vitalize Venture Group, Aditya Raghupathy, Daren Cotter
Apr 1, 2024ID5$20.0M Series B—BDMI - Bertelsmann Digital Media Investments, Origin Ventures, S4S Ventures, Jack Boren
Mar 1, 2024Orq.ai$2.0M Seed—Curiosity VC, FirstMark Capital, Flex Capital, La Famiglia, Portal Ventures, Stash Ventures, Target Global, WGI Group, Kim Perell, Noah Goodhart, Thomas Plantenga
Dec 1, 2023Extropic AI$14.0M Seed—186 Ventures, 7BC Venture Capital, Accomplice VC, Alchemy Ventures, Alt Capital, Andreessen Horowitz, Arrive, Audrey Capital, Bain Capital, Baseline Ventures, Bold Capital Partners, Boston Seed Capital, CRV, E1 Ventures, FirstHand Alliance, foobar.vc, Founder Collective, General Catalyst, Global Founders Capital, Goat Capital, Gradient Ventures, Greenoaks Capital, Grotech Ventures, Haun Ventures, Christian Miele, HOF Capital, Impellent Ventures, Index Ventures, Infinity Ventures Crypto, Initialized Capital, Innovation Endeavors, Jude Gomila Rolling Fund, Kima Ventures, Kindred Ventures, Matchstick Ventures, monashees, Motier Ventures, NextGen Venture Partners, NextView Ventures, Operator Collective, Polychain Capital, Predictive VC, Preston-Werner Ventures, Quassar Capital, Safar Partners, Saga, Samsung NEXT Ventures, Sarona Ventures, Sequoia Capital, The Hit Forge, Union Square Ventures, Village Global, VitalStage Ventures, Y Combinator, Ameet Patel, Amit Agarwal, Amjad Masad, Anjney Midha, Arash Ferdowsi, Balaji Srinivasan, Bob Young, Bradley Horowitz, David Chang, Drew Houston, Eric Wu, Guy Podjarny, Immad Akhund, Jeff Seibert, Jennifer Lum, Lukas Biewald, Mathilde Collin, Sam Altman, Scott Belsky, Stanley Tang, Tim Griffin, Tobias Lutke, Vivek Patel, William Hockey
Nov 1, 2023Alto Neuroscience$45.0M Series C—7BC Venture Capital, Champion Hill Labs, Crosscut Ventures, Endeavor Venture Funds, Scott Hartley, LombardStreet Ventures, Presight Capital, What If Ventures, Tim Kendall
Oct 1, 2023Yardstik$12.0M Series A—Closed Loop Partners, Crosslink Capital, Dimension Capital, Emergence Capital, FirstHand Alliance, Grotech Ventures, Hummingbird Ventures, Matchstick Ventures, MissionOG, Rally Ventures, Stellar Capital, Balaji Srinivasan, Daren Cotter
Oct 1, 2023Prove$40.0M Venture Round—Bessemer Venture Partners, High Alpha, MassMutual Ventures, Menlo Ventures, Jeff Richards
Oct 1, 2023Cleanlab$25.0M Series A—Bain Capital Ventures, Benchmark, Bessemer Venture Partners, Founders Fund, High Alpha, Long Journey Ventures, MassMutual Ventures, Mayfield, Menlo Ventures, Jeff Richards, Signia Venture Partners, Summit Partners, Talis Capital, Tiger Global Management, TQ Ventures, Aleksander Leonard Larsen, Cato Sælid, Eugene Wei, Julius Genachowski, Kevin Lin, Xen Lategan
Oct 1, 2023Orq.ai$840K Seed—Afore Capital, Andreessen Horowitz, Caffeinated Capital, Cherry Ventures, Construct Capital, Countdown Capital, Cubit Capital, Curiosity VC, FirstMark Capital, Flex Capital, Floodgate, Founders Fund, La Famiglia, Lux Capital, Picus Capital, Portal Ventures, Ravelin Capital, Saga, Stash Ventures, Target Global, WGI Group, Harry Hurst, Justin Mateen, Kim Perell, Koen Koeppen, Max Klijnstra, Milan Daniels, Noah Goodhart, Rob Meyerson, Thomas Plantenga
Sep 1, 2023AskFora$2.0M Seed—FirstHand Alliance, Grotech Ventures, Matchstick Ventures, Balaji Srinivasan
Jul 1, 2023Viome Life Sciences$10.0M Series C—Endeavor Venture Funds, Presight Capital, What If Ventures, Tim Kendall
Jun 1, 2023Parallax$12.0M Series B—Grotech Ventures, Hyde Park Venture Partners, Tech Square Ventures
May 1, 2023Checkmate$15.0M Series A—468 Capital, Atomic, Balderton Capital, Bold Capital Partners, Catapult Capital, Cedar Capital Group, DST Global, Endeavor Venture Funds, First Rays Venture Partners, Fuel Capital, General Catalyst, GV, Kaszek Ventures, Latitud, M13, Mischief Venture Capital, monashees, Moxxie Ventures, NextGen Venture Partners, Picus Capital, Presight Capital, Akriti Dokania, Scribble Ventures, Seaside Ventures, Sequoia Capital, Serena Ventures, Sound Ventures, South Park Commons, Version One Ventures, WestCap, What If Ventures, Chris Murphy, Fidji Simo, Lea- Sophie Cramer, Ricardo Weder, Ron Pragides, Simon Borrero, Steph Korey, Tyler Willis
Apr 1, 2023nextmarkets$11.0M Venture Round—Endeavor Venture Funds, Presight Capital, What If Ventures, Tim Kendall
Mar 1, 2023Bicara Therapeutics$110.0M Series B—F-Prime Capital Partners, RA Capital, Red Tree Venture Capital, Samsara BioCapital, Third Rock Ventures
Feb 1, 2023Tracer$18.0M Series A—BDMI - Bertelsmann Digital Media Investments, Origin Ventures, S4S Ventures, Jack Boren
Jan 1, 2023Alleviant Medical$74.0M Venture Round—RiverVest, S3 Ventures